NPs Basic Information

Name
Cyclo(Leu/Ile-Hyp)
Molecular Formula C11H18N2O3
IUPAC Name*
7-hydroxy-3-(2-methylpropyl)-2,3,6,7,8,8a-hexahydropyrrolo[1,2-a]pyrazine-1,4-dione
SMILES
CC(C)CC1NC(=O)C2CC(O)CN2C1=O
InChI
InChI=1S/C11H18N2O3/c1-6(2)3-8-11(16)13-5-7(14)4-9(13)10(15)12-8/h6-9,14H,3-5H2,1-2H3,(H,12,15)
InChIKey
YEHIUWVXPQQDMC-UHFFFAOYSA-N
Synonyms
NA
CAS NA
PubChem CID NA
ChEMBL ID NA
*Note: the IUPAC Name was calculated by STOUT. Reference: PMID:33906675.
Chemical Classification:
  • Kingdom: Organic compounds
    • Superclass: Organic acids and derivat
      • Class: Carboxylic acids and deri
        • Subclass: Amino acids, peptides, an
          • Direct Parent: Alpha amino acids and der

ClassyFire Version 1.0
PMID:27867422

NPs Species Source

Endophyte ID Endophyte Name Family Genus Taxonomy ID GenBank ID Closest GenBank ID Reference
Endophyte ID Endophyte Name Family Genus Taxonomy ID GenBank ID Closest GenBank ID Reference

NPs Content

*Note: The vaules in Content Percentage are calculated by dividing the content value by the maximum content value in NP Content.
**Note: The units with different NP content, due to their incomparable values, are separated into different tables.

NPs Biological Activity

Bioactivity Name Target ID Target Name Target Type Target Organism Target Organism ID Potency of Bioactivity Activity Type Value Unit Endophyte ID Endophyte Name
Bioactivity Name Target ID Target Name Target Type Target Organism Target Organism ID Potency of Bioactivity Activity Type Value Unit Endophyte ID Endophyte Name

NPs Physi-Chem Properties

Molecular Weight: 226.28 ALogp: -0.5
HBD: 2 HBA: 3
Rotatable Bonds: 2 Lipinski's rule of five: Accepted
Polar Surface Area: 69.6 Aromatic Rings: 2
Heavy Atoms: 16 QED Weighted: 0.693

NPs ADMET Properties*

ADMET: Absorption

Caco-2 Permeability: -4.872 MDCK Permeability: 0.00028594
Pgp-inhibitor: 0 Pgp-substrate: 0.102
Human Intestinal Absorption (HIA): 0.069 20% Bioavailability (F20%): 0.003
30% Bioavailability (F30%): 0.004

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB): 0.211 Plasma Protein Binding (PPB): 5.36%
Volume Distribution (VD): 0.696 Fu: 82.33%

ADMET: Metabolism

CYP1A2-inhibitor: 0.016 CYP1A2-substrate: 0.084
CYP2C19-inhibitor: 0.046 CYP2C19-substrate: 0.669
CYP2C9-inhibitor: 0.019 CYP2C9-substrate: 0.603
CYP2D6-inhibitor: 0.007 CYP2D6-substrate: 0.177
CYP3A4-inhibitor: 0.021 CYP3A4-substrate: 0.218

ADMET: Excretion

Clearance (CL): 5.881 Half-life (T1/2): 0.61

ADMET: Toxicity

hERG Blockers: 0.011 Human Hepatotoxicity (H-HT): 0.866
Drug-inuced Liver Injury (DILI): 0.339 AMES Toxicity: 0.013
Rat Oral Acute Toxicity: 0.174 Maximum Recommended Daily Dose: 0.358
Skin Sensitization: 0.122 Carcinogencity: 0.042
Eye Corrosion: 0.003 Eye Irritation: 0.021
Respiratory Toxicity: 0.068
*Note: the ADMET properties was calculated by ADMETlab 2.0. Reference: PMID: 33893803.

Similar Compounds*

Compounds similar to EMNPD with top10 similarity:

Similar NPs Similar Drugs
NPs ID NPs 2D Structure Similarity Score TTD ID Drug 2D Structure Similarity Score
D0R2KF 0.288
D0CL9S 0.236
D09PJX 0.230
D04CSZ 0.220
D0Z4BV 0.220
D09PZO 0.219
D0TS1Z 0.219
D03QWT 0.211
D0S8LV 0.207
D0O5FY 0.204
*Note: the compound similarity was calculated by RDKIT.